you are viewing a single comment's thread.
so when will one of these big stock holder break and sale/
Black box not likely, review the data. The incident level is still half of what it was during the clinical trials and is already part of the marketing materials.Why would the FDA approve the drug with incident levels at .2% and then issue a black box warning at .1%??